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Abstract: Estimating population-level effects of a vaccine is challenging because there may be
interference, i.e., the outcome of one individual may depend on the vaccination status of another
individual. Partial interference occurs when individuals can be partitioned into groups such that
interference occurs only within groups. In the absence of interference, inverse probability weighted
(IPW) estimators are commonly used to draw inference about causal effects of an exposure or
treatment. Tchetgen Tchetgen and VanderWeele (2012) proposed a modified IPW estimator for
causal effects in the presence of partial interference. Motivated by a cholera vaccine study in
Bangladesh, this paper considers an extension of the Tchetgen Tchetgen and VanderWeele IPW
estimator to the setting where the outcome is subject to right censoring using inverse probability
of censoring weights (IPCW). Censoring weights are estimated using proportional hazards frailty
models. The large sample properties of the IPCW estimators are derived, and simulation studies
are presented demonstrating the estimators’ performance in finite samples. The methods are then
used to analyze data from the cholera vaccine study.
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1 Introduction
Estimating population-level effects of a vaccine is challenging because there may be interference,
i.e., the outcome of one individual may depend on the vaccination status of another individual
(Cox, 1958; Halloran and Struchiner, 1991). Partial interference is a special case of interference
where individuals can be partitioned into groups such that interference does not occur between
individuals in different groups but may occur between individuals in the same group (Sobel 2006).
Partial interference might be a reasonable assumption if groups of individuals are sufficiently
separated geographically, socially, and/or temporally. For example, in an assessment of the effects
of cholera vaccination in a study in Bangladesh, Perez-Heydrich et al. (2014) assumed partial
interference based on the spatial location of residences of study participants. Effects due to
interference, also known as spillover effects or peer effects, are of interest in many areas, including
criminology, developmental psychology, econometrics, education, imaging, political science, social
media and network analysis, sociology, and spatial analyses.
Inferential methods about spillover effects have been developed for randomized experiments
(Rosenbaum, 2007; Hudgens and Halloran, 2008; Eckles et al., 2016; Baird et al., 2018). How-
ever, in some settings it may not be feasible or ethical to randomize groups or individuals to
different treatment or exposure conditions. In the observational setting, Tchetgen Tchetgen and
VanderWeele (henceforth TV) (2012) proposed inverse probability weighted (IPW) estimators for
different types of causal effects when there may be partial interference. Large sample properties
of these IPW estimators were considered by Perez-Heydrich et al. (2014) and Liu et al. (2016).
While motivated by observational studies, these estimators may also be applied in cluster (group)
randomized trials where partial interference is assumed and there is non-compliance, i.e., not all
individuals receive the treatment assigned to their cluster. These estimators are also applicable
to settings such as the cholera vaccine study where all individuals in the study were randomized
but only a subset chose to participate in the trial.
In settings where the outcome of interest is a time to event, the outcome may be subject to
right censoring due to study completion or participant drop-out. For example, in the Bangladesh
cholera vaccine trial mentioned above, some study participants emigrated out of the field trial area
and hence were lost to follow-up. In the absence of interference, censoring is often accommodated
by using inverse probability of censoring weights along with inverse probability treatment weights
(Robins and Finkelstein, 2000; Cole and Herna´n, 2008). In this paper, an extension of the TV
IPW estimators is considered for the setting where there may be partial interference and the
outcome is subject to right censoring using inverse probability of censoring weights (IPCW).
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The outline of this paper is as follows. The proposed methods are developed in Section 2.
In Section 3 simulation results are presented demonstrating the empirical performance of the
proposed methods in finite sample settings. In Section 4 the methods are used to analyze the
Bangladesh cholera vaccine study. Section 5 concludes with a discussion.
2 Methods
2.1 Estimands
Suppose data are observed from m groups of individuals, with ni individuals per group for i =
1, . . . ,m. Let Aij = 1 if individual j in group i receives treatment (e.g., vaccine) and Aij = 0
otherwise. Let Ai = (Ai1, Ai2, ..., Aini) and Ai,−j = (Ai1, Ai2, ..., Aij−1, Aij+1..., Aini). Let ai and
ai,−j denote possible realizations of Ai and Ai,−j , and let A(n) denote the set of all possible 2n
treatments for a group size of n = 1, 2, . . .. Assume partial interference and denote the potential
time to event for individual j in group i if, possibly counter to fact, group i receives treatment
ai by Tij(ai). The notation Tij(ai) reflects the partial interference assumption, i.e., the potential
outcome of individual j in group i does not depend on the treatment of individuals outside group
i. Below the notation Tij(a,ai,−j) is sometimes used to make explicit the treatment for individual
j and the treatment for all other individuals in group i. Let Ti(.) = {Tij(ai) : ai ∈ A(ni), j =
1, 2, · · · , ni} denote the set of all potential event times for individuals in group i. Suppose the
event times are subject to right censoring, e.g., due to loss to follow-up or study completion. Let
Cij denote the potential censoring times for individual j in group i. Assume that treatment has no
effect on the censoring times, i.e., Cij does not depend on ai. This assumption is reasonable for the
cholera vaccine study because both the individuals in the study as well as the study investigators
were blinded to treatment assignment. Let ∆ij = 1 if Tij(Ai) ≤ Cij and ∆ij = 0 otherwise,
and let Xij = min(Tij(Ai), Cij). Define Xi = (Xi1, Xi2, · · · , Xini) and ∆i = (∆i1,∆i2, · · · ,∆ini).
Denote by Lij the vector of baseline covariates for subject j in group i and by Li the matrix of
baseline covariates for all subjects in group i, i.e., Li = (Li1,Li2, · · · ,Lini). Assume that the m
groups are randomly sampled from an infinite superpopulation of groups such that the observed
data are m i.i.d. copies of Oi = (Li,Ai,Xi,∆i).
In the absence of interference, treatment effects are typically defined as contrasts in mean po-
tential outcomes for different counterfactual scenarios, e.g., the average treatment effect is usually
defined as the difference in the mean potential outcome had all individuals received treatment
versus had no individuals received treatment. Similarly, in the setting where there is partial
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interference, causal effects may be defined as contrasts in mean potential outcomes for different
counterfactual scenarios (Hong and Raudenbush, 2006; Sobel, 2006; Hudgens and Halloran, 2008;
Tchetgen Tchetgen and VanderWeele, 2012). Here we consider counterfactual scenarios where
the marginal probability that an individual receives treatment, Prα(Aij = 1), equals α for differ-
ent values of α ∈ (0, 1). The notation Prα(·) indicates that the probability corresponds to the
distribution under the counterfactual scenario. Specifically, the Bernoulli treatment allocation
strategy (or policy) described in TV is considered wherein individuals independently select treat-
ment with probability α. Let pi(ai, α) denote the probability that group i receives treatment ai
under Bernoulli allocation strategy α. That is, pi(ai, α) = Prα(Ai = ai) =
∏ni
k=1 α
aik(1−α)1−aik .
Similarly let pi(ai,−j , α) = Prα(Ai,−j = ai,−j |Aij = a) =
∏ni
k=1,k 6=j α
aik(1− α)1−aik .
The causal estimands of interest defined below are contrasts in the risk of having an event
by time t for different combinations of treatment a and allocation strategies α. To define these
estimands, let
F¯ij(t, a, α) =
∑
ai,−j∈A(ni−1)
I{Tij(a,ai,−j) ≤ t}pi(ai,−j , α),
and
F¯ij(t, α) =
∑
ai∈A(ni)
I{Tij(ai) ≤ t}pi(ai, α).
In words, F¯ij(t, a, α) is the probability that individual j in group i will have an event by time
t when receiving treatment a and the group adopts policy α. Likewise, F¯ij(t, α) is the prob-
ability that individual j in group i will have an event by time t when the group adopts al-
location strategy α. Denote the group average risks by F¯i(t, a, α) = n
−1
i
∑ni
j=1 F¯ij(t, a, α) and
F¯i(t, α) = n
−1
i
∑ni
j=1 F¯ij(t, α). Let µ(t, a, α) = Eα{F¯i(t, a, α)} and µ(t, α) = Eα{F¯i(t, α)} where
Eα{.} denotes the expected value under the counterfactual setting when policy α is adopted in the
superpopulation of groups. In the cholera vaccine study described in Section 4, µ(t, a, α) denotes
the average risk of acquiring cholera by time t when an individual receives treatment a and other
individuals receive vaccine with probability α.
Various effects of treatment can be defined by contrasts in µ(t, a, α) and µ(t, α) (Tchetgen Tch-
etgen and VanderWeele, 2012; Perez-Heydrich et al., 2014). The direct effect is obtained by
comparing the probability of an event when an individual receives treatment versus when not
receiving treatment for a fixed allocation strategy. In particular, the direct effect at time t
corresponding to policy α is defined to be DE(t, α) = µ(t, 0, α) − µ(t, 1, α). The indirect (or
spillover) effect is the difference in the probability of an event by time t for two different poli-
cies when the individual does not receive treatment. Specifically, the indirect effect is given
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by IE(t, α1, α2) = µ(t, 0, α1) − µ(t, 0, α2) for allocation strategies α1 and α2. An indirect ef-
fect can analogously be defined when an individual is vaccinated. The total effect is defined as
the difference between the probability of an event by time t when an individual does not re-
ceive treatment under policy α1 and when an individual receives treatment under policy α2, i.e.,
TE(t, α1, α2) = µ(t, 0, α1) − µ(t, 1, α2). Finally, the overall effect is the difference between the
probability of an event by time t for policy α1 versus α2, i.e., OE(t, α1, α2) = µ(t, α1)− µ(t, α2).
2.2 Assumptions
Assume the following:
I) Conditional independent treatment: Ai ⊥ Ti(.) | Li
II) Treatment positivity: Pr(Ai = ai | Li) > 0 for all ai ∈ A(ni)
III) Conditional independent censoring: Cij ⊥ Tij(Ai) | {Li,Ai}
IV) Non-censoring positivity: Pr(∆ij = 1 | Li,Ai) > 0
Assumption I states that the potential event times for individuals within the same group
are conditionally independent of the actual treatment received by the group given covariates;
this is a group-level generalization of the usual individual-level no unmeasured confounders as-
sumption often made in the absence of interference (Tchetgen Tchetgen and VanderWeele, 2012).
Assumption I would be violated if there was some common cause of one or more components of
Ai and Ti(·) not included in Li. Treatment positivity assumes that each group has a non-zero
probability of being assigned every possible treatment combination given covariates for the group
(Perez-Heydrich et al., 2014). Assumption II would not hold if there was some group which had
zero chance of receiving some treatment combination (e.g., treatment a = 1 for all individuals
in the group). Assumption III supposes that conditional on baseline group covariates and group
treatment, an individual’s failure time is independent of their censoring time. Assumption III
would be violated if there was some variable not in Li or Ai which was prognostic of both the
censoring and failure times. Finally Assumption IV indicates that each individual has a non-zero
probability of not being censored at each observation time (Rotnitzky et al., 2007). In the next
section IPW estimators are proposed and shown to be consistent (and asymptotically normal) for
the direct, indirect, total, and overall effects under Assumptions I-IV.
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2.3 Proposed Estimator
In the absence of censoring, the IPW estimator proposed by TV can be used to draw inference
about µ(t, a, α) and µ(t, α), i.e., the mean potential outcomes under the counterfactual setting
where policy α is adopted. In particular, letting Yij = I(Xij ≤ t) be the indicator variable that
the observation time for individual j in group i is less than or equal to t, the TV IPW estimators
are µˆTV (t, a, α) = m−1
∑m
i=1 Fˆ
TV
i (t, a, α) and µˆ
TV (t, α) = m−1
∑m
i=1 Fˆ
TV
i (t, α) where
Fˆ TVi (t, a, α) = n
−1
i
ni∑
j=1
pi(Ai,−j ;α)I(Aij = a)Yij
Pr(Ai|Li, βˆ)
, Fˆ TVi (t, α) = n
−1
i
ni∑
j=1
pi(Ai;α)Yij
Pr(Ai|Li, βˆ)
,
and βˆ is an estimator of the vector of parameters for the propensity model Pr(Ai|Li,β). Details
of the propensity model are discussed in the next sections.
In the presence of censoring, the following extension of the TV IPW estimators is proposed:
µˆ(t, a, α) = m−1
∑m
i=1 Fˆi(t, a, α) and µˆ(t, α) = m
−1∑m
i=1 Fˆi(t, α) where
Fˆi(t, a, α) = n
−1
i
ni∑
j=1
pi(Ai,−j ;α)I(Aij = a)I(∆ij = 1)I(Xij ≤ t)
Pr(Ai|Li, βˆ)SC(Xij |Li,Ai, γˆ)
,
Fˆi(t, α) = n
−1
i
ni∑
j=1
pi(Ai;α)I(∆ij = 1)I(Xij ≤ t)
Pr(Ai|Li, βˆ)SC(Xij |Li,Ai, γˆ)
,
SC(t|Li,Ai, γˆ) = Pr(Cij > t | Li,Ai, γˆ) and γˆ is an estimator of the vector of the parameters for
the censoring model. Details of the censoring model are discussed in the next sections. Estimates
of the direct, indirect, total, and overall effects are given by D̂E(t, α) = µˆ(t, 0, α) − µˆ(t, 1, α),
ÎE(t, α1, α2) = µˆ(t, 0, α1)− µˆ(t, 0, α2), T̂E(t, α1, α2) = µˆ(t, 0, α1)− µˆ(t, 1, α2) and ÔE(t, α1, α2) =
µˆ(t, α1)− µˆ(t, α2).
The proposition below shows that if the group level propensity scores and the individual
censoring probabilities are known, then the proposed IPCW estimators are unbiased. A proof of
the proposition is given in Appendix A.
Proposition. If Pr(Ai|Li) and SC(Xij |Li,Ai) are known for j = 1, 2, . . . , ni and i = 1, . . . ,m,
and then E{µˆ(t, a, α)} = µ(t, a, α) and E{µˆ(t, α)} = µ(t, α).
In observational studies, the conditional distribution of treatment given covariates is unknown.
Likewise, in both observational studies as well as randomized trials, the conditional distribution
of censoring given covariates is typically not known (one exception being studies or trials without
drop-out such that the only cause of censoring is the end of administrative follow-up at some fixed
time point). Therefore, we consider finite dimensional parametric models to estimate the group
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propensity scores and conditional probability of censoring; these estimates are then plugged into
the IPCW estimators defined above.
The conditional probability of censoring is estimated using a shared frailty model (Munda
et al., 2012) where the conditional hazard for Cij is assumed to have the proportional hazards
form gij(c|Li,Ai, ei) = g0(c;θh)ei exp (L˜Tijθc), where g0 is the baseline hazard function, θh is the
q′- dimensional parameter vector of the baseline hazard function, ei is a random effect with density
fe(ei; θr), L˜ij is some user specified function of {Li,Ai}, and θc is the q-dimensional vector of
coefficients. The vector L˜ij could include, for example, covariates and treatment for individual
j (i.e., Lij and Aij) as well as the proportion of others in the group who receive treatment (i.e.,∑
k 6=j Aik/(ni − 1)). Below the dependence of g0 on θh is suppressed for notational convenience.
Let γ = (θc,θh, θr) be the vector of parameters for the frailty model. Maximum likelihood theory
can be used to draw inference about γ. Under assumption III, the contribution of group i to the
log-likelihood corresponding to the frailty censoring model is (Munda et al., 2012)
l(Xi,∆i,Li,Ai,γ) =
ni∑
j=1
∆ij
[
log{g0(Xij)}+ L˜Tijθc
]
+ (−1)diL(di)
ni∑
j=1
G0(Xij) exp (L˜
T
ijθc),
where di =
∑ni
j=1(1−∆ij) is the number of censored observations in group i, G0(ω) =
∫ ω
0 g0(κ)dκ,
and L(s) = ∫∞0 exp (−eis)fe(ei; θr)dei. Therefore, the maximum likelihood estimator of γ solves
the following estimating equations∑
i
ψck(Xi,∆i,Li,Ai,γ) = 0 for k = 1, ..., q + q
′ + 1,
where ψck = ψck(Xi,∆i,Li,Ai,γ) = ∂l(Xi,∆i,Li,Ai,γ)/∂γk and γk is the k-th element of γ.
Below, the baseline hazard for the censoring model is assumed to be constant and equal to θh,
and the frailty term ei is assumed to follow a Gamma distribution with mean 1 and variance θr,
such that censoring weights for an uncensored individual can be computed via
SC(t|Li,Ai,γ) =
∫
Pr(Cij > t|L˜ij ,γ, ei)fe(ei; θr)dei
=
∫
exp {−θht exp (L˜ijθc)ei}e
1/θr−1
i e
−ei/θr
θ
1/θr
r Γ(1/θr)
dei
=
{
1
θrθht exp (L˜ijθc) + 1
}1/θr
Following TV (2012), a mixed effects model may be assumed for the treatment allocation, i.e.,
Pr(Aij = 1|Lij , bi) = logit−1(Lijθx+bi) where bi is a random effect following density fb(bi; θs). (In
the application below the mixed effects model has a slightly more complicated form owing to the
particulars of the design of the study analyzed.) Let β = (θx, θs) denote the (p+ 1) dimensional
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vector of parameters for the mixed effects model. Again, maximum likelihood theory can be used
to draw inference about β. The contribution of group i to the log-likelihood for the mixed effects
model is given by
l(Ai,Li,β) = log
∫ ni∏
j=1
hij(bi,Li,θx)
Aij{1− hij(bi,Li,θx)}(1−Aij)fb(bi; θs)
,
where hij(bi,Li,β) = Pr(Aij = 1|Lij , bi). The maximum likelihood estimator of β is the solution
to the score equations ∑
i
ψxk(Ai,Li,β) = 0 for k = 1, ..., p+ 1,
where ψxk = ψxk(Ai,Li,β) = ∂l(Ai,Li,β)/∂βk and βk is the k-th element of β.
Inference about the causal effects of interest is then based on solving the vector of estimating
equations ∑
i
ψ(Oi,θ) = 0, (1)
where θ = (γ,β, θ), ψ(Oi,θ) = (ψc,ψx, ψaα)
T , ψc =
(
ψc1, ψc2, ..., ψcq+q′+1
)T
, ψx =
(ψx1, ψx2, ..., ψxp+1)
T ,
ψaα = ψaα(Oi,θ) =
g∗(Oi, a, α,γ)
Pr(Ai|Li,β) − θ,
and
g∗(Oi, a, α,γ) = n−1i
n∑
j=1
pi(Ai,−j ;α)I(Aij = a)I(Xij ≤ t)
SC(Xij |Li,Ai,γ) .
Let θˆ = (γˆ, βˆ, µˆ(t, a, α)) denote the solution to (1). Denote the true value of θ by θ0 =
(γ0,β0, µ(t, a, α)) and note that∫
ψaα(o,γ0,β0, µ(t, a, α))dFO(o) = E
{
g∗(Oi, a, α,γ0)
Pr(Ai|Li,β0)
− µ(t, a, α)
}
= 0,
where FO denotes the joint distribution of the complete observed random variable O and the
last equality follow from the Proposition above. Therefore, assuming the parametric models
above are correctly specified, it follows that
∫
ψ(o,θ0)dFO(o) = 0. By M-estimation theory
(Stefanski and Boos, 2002), θˆ
p→ θ0 and
√
m(θˆ − θ0) converges in distribution to a Normal
distribution with mean 0 and covariance matrix Σ equal to U(θ0)
−1V (θ0){U(θ0)−1}T where
U(θ0) = E{−ψ˙(Oi,θ0)}, V (θ0) = E{ψ(Oi,θ0)ψ(Oi,θ0)T }, and ψ˙(Oi,θ) = ∂ψ(Oi,θ)/∂θT .
Consistency and asymptotic normality of the direct, indirect and total effect estimators follows
from the delta method. Similar techniques can be used to show that µˆ(t, α) and the overall
effect estimator are also consistent and asymptotically Normal. The asymptotic variance Σ can
be consistently estimated by Σˆ = Uˆ(θˆ)−1Vˆ (θˆ){Uˆ(θˆ)−1}T where Uˆ(θˆ) = m−1∑mi=1{−ψ˙(Oi, θˆ)}
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and Vˆ (θˆ) = m−1
∑m
i=1{ψ(Oi, θˆ)ψ(Oi, θˆ)T }. The empirical sandwich variance estimator Σˆ can be
computed using the R package geex (Saul and Hudgens, 2019) and can be used to construct Wald
type confidence intervals (CIs).
3 Simulation Study
A simulation study was conducted to assess the finite sample bias of the IPCW estimator and
coverage of the corresponding Wald confidence intervals. The data generating model used in the
simulation study was motivated by aspects of the cholera vaccine study analysis presented in
the next section. Following Perez-Heydrich et al. (2014), data were simulated according to the
following steps.
i) First, two baseline covariates L1ij and L2ij were randomly generated. In the application
presented in Section 4, conditional independence (assumption I) is assumed given an indi-
vidual’s age (in decades) and the distance of their residence to the nearest river. Motivated
by this example, L1ij (age) and L2ij (distance to river) were randomly generated as follows.
First, Vij was randomly generated from an Exponential distribution with mean 20, r1i from
Normal(0, 0.1), and r2ij from Normal(0, 0.1). Then L1ij was set to min(Vij+r1i+r2ij , 100)/10
and L2ij randomly generated such that logL2ij ∼ Normal(r1i + r2ij , 0.75).
ii) The random effects for the treatment model bi were randomly sampled from a Normal dis-
tribution with mean 0 and variance 0.0859.
iii) The treatment indicators Aij were randomly sampled from a Bernoulli distribution with mean
pij = expit(0.2727− 0.0387L1ij + 0.2179L2ij + bi).
iv) The potential times to event Tij(ai) were randomly sampled from an Exponential distribution
with mean µij = 200 + 100aij − 0.98L1ij − 0.145L2ij + 50
∑
k 6=j aik/ni.
v) The random effects for the censoring model ei were randomly generated from a Gamma
distribution with mean 1 and variance θ = 1.25.
vi) Censoring times Cij were randomly sampled from an Exponential distribution with mean
1/λ0 where λ0 = 0.015 exp (0.002L1ij + 0.015L2ij)ei.
vii) Individual censoring indicators were determined, i.e., ∆ij = 0 if Cij < Tij(Ai).
Steps i through vii were used to stochastically generate 1000 data sets, with each data set
containing 500 groups with 10 individuals per group. For each simulated data set, the IPCW
9
α µ(100, 0, α) Bias ESE ASE EC α µ(100, 1, α) Bias ESE ASE EC
0.1 0.39 0.02 0.07 0.07 94% 0.1 0.28 0.01 0.08 0.08 92%
0.2 0.38 0.01 0.04 0.04 96% 0.2 0.27 0.01 0.04 0.04 95%
0.3 0.38 0.00 0.03 0.03 96% 0.3 0.27 -0.00 0.03 0.03 95%
0.4 0.37 -0.00 0.03 0.02 95% 0.4 0.27 -0.01 0.02 0.02 94%
0.5 0.36 -0.00 0.03 0.02 94% 0.5 0.26 -0.00 0.02 0.02 93%
0.6 0.36 -0.01 0.03 0.02 94% 0.6 0.26 -0.00 0.02 0.02 93%
0.7 0.35 -0.00 0.03 0.02 94% 0.7 0.26 -0.01 0.02 0.01 94%
0.8 0.35 -0.01 0.03 0.03 94% 0.8 0.25 -0.00 0.02 0.02 93%
0.9 0.34 -0.00 0.05 0.05 92% 0.9 0.25 0.01 0.02 0.02 95%
Table 1: Results from simulation study described in Section 3. α denote the allocation proba-
bilities, µ(100, a, α) is the true value of the target parameter for a = 0, 1; Bias is the average of
µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error; ASE is the average of
the sandwich variance based standard error estimates; and EC denotes the empirical coverage of
the 95% Wald confidence intervals.
estimator of µ(100, a, α) was evaluated for a = 0, 1 and α = 0.1, 0.2, . . . , 0.9. Estimated standard
errors based on the empirical sandwich variance estimator and Wald 95% confidence intervals
were also calculated for each simulated data set. Empirical standard errors were calculated by
taking the standard deviation of the point estimates from all simulations.
The true value of the estimand was obtained by simulating counterfactual outcomes for m =
106 groups of individuals. Note that, according to the model used to generate the data, potential
survival times depend only on
∑
k 6=j aik. So, µ(t, a, α) was approximated by (Perez-Heydrich
et al., 2014)
m−1
m∑
i=1
n−1i
ni∑
j=1
ni−1∑
k=0
(
ni − 1
k
)
I{Tij(a, k) ≤ t}αk(1− α)ni−k−1.
The true value of µ(t, α) was determined in a similar fashion.
Results from the simulation study are presented in Table 1. Bias of the IPCW estimator was
negligible for all values of a and α. Likewise, the average estimated standard error was close to
the empirical standard error. Coverage of the 95% Wald CIs was approximately equal to the
nominal level.
Additional simulation studies were conducted to assess the performance of the proposed
methods for different values of m, the total number of groups, ranging from 10 to 500. The
number of individuals per group was 10, as in the previous simulations. For each m ∈
10
Figure 1: Absolute bias (left) and 95% confidence interval coverage (right) for different numbers
of groups for α = 0.5. The dotted line in the right plot corresponds to 95% coverage.
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{10, 50, 100, 200, 300, 400, 500}, 1000 data sets were simulated according to steps i through vii
above. Results are depicted in Figure 1. Bias of the IPCW estimator was small and coverage of
the Wald CIs was close to the nominal level provided m was at least 50. Additional details of
these simulation results are provided in Appendix Tables 1–5. In cluster randomized trials with
small numbers of clusters, Wald-type CIs are often constructed using a t distribution with m− r
degrees of freedom, where r is the number of parameters being estimated, rather than a Normal
distribution; empirical coverage of Wald CIs using the t distribution is also shown in Appendix
Tables 1–5 and was similar to coverage based on the Normal distribution.
4 Application
4.1 Cholera Vaccine Study and Analysis
In this section, the methods described in Section 2 are used to analyze a cholera vaccine study
in Matlab, Bangladesh (Ali et al., 2005). Eligible study participants were children 2–15 years of
age and women greater than 15 years old. All 121, 975 eligible individuals in the population were
randomized to one of three vaccination groups: B subunit-killed whole-cell oral cholera vaccine,
killed whole-cell-only cholera vaccine, and E. coli K12 placebo. As in Perez-Heydrich et al. (2014),
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no distinction is made between the two vaccines in the analysis presented here. Individuals were
considered to have participated in the randomized trial component of the study if they received
two or more doses of vaccine or placebo. The primary endpoint of the trial was incident cholera.
Three health centers in the Matlab area served as surveillance centers and collected endpoint data
on all individuals, regardless of whether they participated in the randomized trial. The analysis
presented here includes data from all individuals, i.e., trial participants as well as those who chose
not to participate. Thus an approach which accounts for possible confounding, such as the IPW
method described in Section 2, should be utilized to assess the effects of vaccination.
Previous analyses of this study suggest the presence of interference (Ali et al., 2005; Perez-
Heydrich et al., 2014). Interference is plausible in the setting because the vaccine may (i) prevent
an individual from contracting cholera or (ii) decrease the infectiousness or contagiousness of an
individual who does contract cholera; for either (i) or (ii), the vaccine would make it less likely
that such an individual would subsequently infect other individuals. However, these previous
analyses did not formally account for censoring. Here individuals are considered right censored
if they were not diagnosed with cholera during the study. Individuals who emigrated from the
study location or died during the follow-up period prior to cholera infection were right censored
at the time of emigration or death. Individuals who did not emigrate or die and who did not
develop cholera during the study were right censored at the end of the study period.
Related individuals in Matlab live in clustered sets of houses called baris. There were a total
of 6,415 baris at the time of the vaccine trial. Perez-Heydrich et al. (2014) used a clustering
algorithm to form groups (neighborhoods) based on the spatial location of the baris, with the
number of groups pre-specified to be 700. The analysis here is based on the same groups as in
Perez-Heydrich et al. and assumes that there is no interference between individuals in different
groups, i.e, the vaccination of an individual in one group has no effect on whether an individual
in another group contracts cholera. When fitting the propensity model Pr(Ai|Li,β) described
below, the largest 15 groups had estimated group propensity scores that were effectively equal to
zero and therefore these groups were omitted.
Individuals participating in the vaccine trial were not all vaccinated on the same calendar
day, such that the level of vaccine coverage within a group varied over a relatively brief period
of calendar time at the study onset. For simplicity and because the methods developed above do
not accommodate time varying treatment, the start of follow-up for all individuals in a particular
group was set to the latest date of second vaccination among all individuals in that group. Obser-
vations were excluded if individuals contracted cholera (60), died (346), or emigrated (3671) prior
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to the start of follow-up for their group. In total, 94,234 individuals were included in the analysis.
Among these individuals, 55,413 were unvaccinated, either because they received placebo or they
did not participate, and 38,821 were vaccinated with one of the two vaccines. During follow-up,
there were 280 incident cases of cholera among the unvaccinated individuals and 74 cholera cases
among the vaccinated individuals.
As in Perez-Heydrich et al., the group propensity score was modeled using a mixed effects
model. The particular form of the model derives from the fact that in order for an individual
to have received a vaccine, they must have (i) chosen to participate in the trial, and (ii) been
randomized to receive one of the two vaccines. To account for (i), a logistic regression model for
participation was assumed. As in Perez-Heydrich et al., covariates in the participation component
of the model were age, squared age, distance to nearest river, and squared distance to nearest river.
Accommodating (ii) in the propensity model is straightforward because, due to randomization,
individuals who elected to participate in the trial were known to receive one of the two vaccines
with probability 2/3. Combining these two aspects of the model, the propensity score for group
i was estimated by
Pr(Ai|Li, βˆ) =
∫ ni∏
j=1
{(2/3)hij(bi,Lij , θˆx)}Aij{1− (2/3)hij(bi,Lij , θˆx)}(1−Aij)fb(bi; θˆs),
where hij(bi,Li,θx) = Pr(Bij = 1|bi,Lij ,θx) = expit(Lijθx + bi), Bij is the indicator of partic-
ipation, i.e., Bij = 1 if individual j in group i participated in the randomized trial and Bij = 0
otherwise, and (θˆx, θˆs) is the maximum likelihood estimate of (θx, θs). Censoring was modeled
using the Gamma frailty model described above, and only included age as a covariate as no other
variables were associated with censoring. Over 70% of individuals belonged to groups where the
vaccine coverage was between 0.3 and 0.6. Therefore, the analysis was conducted for allocation
strategies ranging from 0.3 to 0.6.
4.2 Results
Figure 2 shows the IPCW estimates of the cumulative probability of cholera over time for al-
location strategies 0.3, 0.45, and 0.6, both when an individual receives a vaccine and when an
individual is unvaccinated. Figure 1 shows that the estimated risk of cholera when an individual is
unvaccinated decreases dramatically as α increases, suggesting the presence of interference. This
decrease is more modest when an individual is vaccinated, indicating a stronger indirect effect
when unvaccinated. At all time points the estimated risk of cholera is higher when an individual
is unvaccinated, suggesting a beneficial, direct effect of vaccination, especially at lower coverage
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Figure 2: Estimated cumulative probability of cholera over time when vaccinated or unvaccinated
for α = 0.3 (left), α = 0.45 (center) and α = 0.6 (right)
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levels. For α = 0.3 and α = 0.45, the estimated risk when unvaccinated increases suddenly
between 200 and 300 days, and then again between 300 and 400 days. These results might be
attributable to the known bimodal seasonality of cholera in Bangladesh (Longini et al., 2002).
Note that, because the study start date varied across groups, the time scale in this analysis does
not exactly coincide with calendar time. Nonetheless, 95% of individuals had a start date within a
two calendar month range, such that there is a strong correlation between the analysis time scale
and calendar time, and thus cholera seasonality may explain these periods of marked increase in
risk.
Direct, indirect, total and overall effect estimates and 95% CIs (×1000) for different allocation
strategies at time t = 1 year are shown in Figure 3. The direct effect estimates generally decrease
as α increases. For example, the direct effect estimate for α = 0.35 is 3.6 (95% CI 1.1, 6.2) whereas
for α = 0.5 the direct effect estimate is 1.5 (95% CI −0.5, 3.5). The indirect, total, and overall
effect estimates in Figure 3 compare the risk of cholera over a range of allocation probabilities
α1 ∈ [0.3, 0.6] versus α2 = 0.4. Here the indirect effect contrasts risk of cholera infection when
individuals are unvaccinated. For larger values of α1 the 95% CIs for these effects exclude the
null value of zero. For example, for α1 = 0.6 the indirect effect estimate is 2.8 (95% CI 1.1, 4.5),
providing statistical evidence of the presence of interference. These results indicate that when
individuals are unvaccinated, the risk of cholera infection is significantly reduced by increasing the
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Figure 3: Direct, indirect, total and overall effect estimates (×1000) for different allocation strate-
gies at time t = 1 year. Indirect, total, and overall effects are with respect to α2 = 0.4. The
shaded regions denote pointwise 95% confidence intervals of the estimates.
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level of vaccine coverage in their neighborhood. The total effect estimates quantify the combined
direct and indirect effects of the vaccine. The overall effect estimates may be of greatest interest
from a public health or policy perspective. For α1 = 0.6, the overall effect estimate is 2.2 (95%
CI 0.9, 3.4); in words, 2.2 fewer cases of cholera per 1000 individuals per year are expected if 60%
of individuals are vaccinated compared to if only 40% of individuals receive vaccine.
In previous analyses of these data, Perez-Heydrich et al. also estimated the direct, indirect,
total and overall effects using a binary outcome indicating whether an individual was infected
with cholera during the first year of follow-up. The IPCW estimates for t = 1 are similar to
these previous results, e.g., Perez-Heydrich et al. estimated the direct effect for α = 0.32 to be
5.3 (95% CI 2.5, 8.1) whereas the IPCW estimate of this effect at t = 1 is 4.0 (95% CI 1.6, 6.5).
However, the Perez-Heydrich et al. estimates may be biased because they did not account for
right censoring. That said, the IPCW results should still be viewed cautiously and only have
valid causal interpretation if Assumptions I - IV hold and the treatment and censoring models
are correctly specified.
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5 Discussion
In this paper, the TV IPW estimator for partial interference was extended to allow for right
censored outcomes. The proposed estimator was obtained by weighting the original TV estimator
by censoring weights calculated from a parametric frailty model of the censoring times. The esti-
mator was shown to be consistent and asymptotically Normal (under identifiability Assumptions
I - IV), and a consistent estimator of the asymptotic variance was proposed. A simulation study
demonstrated that the proposed methods performed well in finite samples provided the number
of groups is sufficiently large. Analysis of a cholera vaccine study using the proposed methods
suggests vaccination had both a direct and indirect effect against cholera infection. These results
are in accordance with findings by Ali et al. (2005) and Perez-Heydrich et al. (2014), but are likely
more accurate since these previous analyses did not formally account for right censoring.
There are several areas of possible future research related to the methods developed here.
For example, further research could entail developing estimators which perform well in settings
where the number of groups (m) is small. The IPCW estimator also presents computational
challenges when group sizes (ni’s) are large because the corresponding estimated group propensity
scores can be approximately zero; other approaches are needed to better accommodate larger
groups. Validity of the IPCW estimator requires correct specification of parametric models, such
that it is important to assess model fit in application of this method. Further research could
entail extensions which utilize semi-parametric data-adaptive methods instead. Extensions of
the IPCW estimator could also be considered for the setting where there is general interference,
i.e., where interference is not restricted to individuals within the same group. In this paper
only Horwitz-Thompson type IPCW estimators were considered; further research could entail
developing stabilized or Hajek type (Liu et al., 2016) IPCW estimators for right censored data
which may be more stable and less variable.
Methods could also be developed allowing for the proportion of treated individuals to vary
over time, which perhaps could entail adapting existing methods which accommodate time varying
exposures and confounding but assume no interference between individuals. The approach con-
sidered in this paper could also be extended to allow for the possibility of “covariate interference,”
i.e., the covariate values of one individual could affect the outcome of another individual (Balzer
et al., 2019; Prague et al., 2016). Finally, following Tchetgen Tchetgen and VanderWeele (2012)
and Perez-Heydrich et al. (2014), here we consider causal estimands corresponding to counter-
factual scenarios where individuals independently select treatment with probability α; in future
research alternative estimands, such as in Barkley et al. (2017), could be considered which may
16
be more relevant to public health officials determining vaccine policy.
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Appendix A. Proposition Proof
From the definition of the IPCW estimator,
E{Fˆi(t, a, α)} = E

ni∑
j=1
pi(Ai,−j ;α)I(Aij = a)I(∆ij = 1)I(Xij ≤ t)
SC(Xij |Li,Ai) Pr(Ai|Li)ni
 (2)
Noting ∆ij = 1 if and only if Cij > Tij(Ai), by the law of total expectation and causal consistency
the right side of (1) can be expressed as
ELi,Ai,Tij(Ai)ECij |Li,Ai,Tij(Ai)
 ni∑
j=1
pi(Ai,−j ;α)I(Aij = a)I{Cij > Tij(A)}I{Tij(Ai) ≤ t}
SC{Tij(A)|Li,Ai}Pr(Ai|Li)ni

Moving the inner expectation inside the summation and taking out terms that are constant with
respect to that expectation, it follows that E{Fˆi(t, a, α)} equals
ELi,Ai,Tij(Ai)
 ni∑
j=1
pi(Ai,−j ;α)I(Aij = a)E{I(Cij > Tij(Ai))|Li,Ai, Tij(Ai)}I{Tij(Ai) ≤ t}
SC{Tij(Ai)|Li,Ai}Pr(Ai|Li)ni

Note by Assumption III that for any t
Sc(t|Li,Ai) = Pr{Cij > t|Li,Ai, Tij(Ai) = t} = E{I(Cij > t)|Li,Ai, Tij(Ai) = t}
Therefore
E{Fˆi(t, a, α)} = EAi,Li,Tij(Ai)
[∑ni
j=1 pi(Ai,−j ;α)I(Aij = a)I{Tij(Ai) ≤ t}
Pr(Ai|Li)ni
]
.
The remainder of the proof follows from the proof of Theorem 6 of Tchetgen Tchetgen and
VanderWeele (2012).
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Appendix Tables
Appendix Table 1
Simulation results for m = 50 and ni = 10 for all i, where: α denotes the allocation probabilities;
µa denotes denotes the value of the target parameters µ(100, a, α) for a = 0, 1; Bias is the
average of µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error; ASE is
the average of the sandwich variance based standard error estimates; EC denotes the empirical
coverage of the 95% Wald confidence intervals based on the Normal distribution; and ECt
denotes empirical coverage of t distribution-based Wald CIs.
α µ0 Bias ESE ASE EC ECt α µ1 Bias ESE ASE EC ECt
0.1 0.39 -0.01 0.25 0.17 76% 77% 0.1 0.28 -0.01 0.28 0.17 64% 64%
0.2 0.38 -0.01 0.13 0.11 86% 87% 0.2 0.27 -0.00 0.15 0.12 79% 80%
0.3 0.37 -0.00 0.10 0.09 88% 89% 0.3 0.27 0.00 0.10 0.08 87% 87%
0.4 0.37 0.00 0.08 0.07 89% 90% 0.4 0.27 0.00 0.07 0.06 90% 90%
0.5 0.36 0.01 0.07 0.07 90% 91% 0.5 0.26 0.00 0.06 0.05 90% 91%
0.6 0.36 0.01 0.07 0.06 90% 91% 0.6 0.26 0.00 0.05 0.05 90% 91%
0.7 0.35 0.01 0.07 0.07 88% 89% 0.7 0.26 0.00 0.05 0.04 92% 93%
0.8 0.35 0.01 0.10 0.09 88% 89% 0.8 0.25 0.00 0.05 0.05 92% 92%
0.9 0.34 0.00 0.16 0.13 84% 84% 0.9 0.25 -0.00 0.07 0.06 90% 90%
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Appendix Table 2
Simulation results for m = 100 and ni = 10 for all i, where: α denotes the allocation
probabilities; µa denotes denotes the value of the target parameters µ(100, a, α) for a = 0, 1; Bias
is the average of µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error;
ASE is the average of the sandwich variance based standard error estimates; EC denotes the
empirical coverage of the 95% Wald confidence intervals based on the Normal distribution; and
ECt denotes empirical coverage of t distribution-based Wald CIs.
α µ0 Bias ESE ASE EC ECt α µ1 Bias ESE ASE EC ECt
0.1 0.39 -0.02 0.20 0.15 83% 84% 0.1 0.28 -0.01 0.20 0.14 77% 78%
0.2 0.38 -0.01 0.10 0.09 91% 91% 0.2 0.27 -0.01 0.10 0.09 87% 87%
0.3 0.37 -0.01 0.07 0.06 91% 91% 0.3 0.27 -0.00 0.07 0.06 91% 91%
0.4 0.37 -0.01 0.06 0.05 93% 93% 0.4 0.27 0.00 0.05 0.05 93% 94%
0.5 0.36 -0.00 0.05 0.05 93% 94% 0.5 0.26 0.00 0.04 0.04 93% 93%
0.6 0.36 0.00 0.05 0.05 92% 93% 0.6 0.26 0.00 0.04 0.03 92% 93%
0.7 0.35 0.00 0.06 0.05 92% 92% 0.7 0.26 0.00 0.04 0.03 91% 91%
0.8 0.35 0.01 0.07 0.06 90% 90% 0.8 0.25 -0.00 0.04 0.03 92% 93%
0.9 0.34 0.01 0.11 0.10 88% 88% 0.9 0.25 -0.01 0.05 0.05 93% 93%
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Appendix Table 3
Simulation results for m = 200 and ni = 10 for all i, where: α denotes the allocation
probabilities; µa denotes denotes the value of the target parameters µ(100, a, α) for a = 0, 1; Bias
is the average of µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error;
ASE is the average of the sandwich variance based standard error estimates; EC denotes the
empirical coverage of the 95% Wald confidence intervals based on the Normal distribution; and
ECt denotes empirical coverage of t distribution-based Wald CIs.
α µ0 Bias ESE ASE EC ECt α µ1 Bias ESE ASE EC ECt
0.1 0.39 -0.01 0.12 0.11 87% 87% 0.1 0.28 -0.01 0.13 0.11 86% 86%
0.2 0.38 -0.01 0.06 0.06 94% 94% 0.2 0.27 -0.01 0.07 0.07 91% 91%
0.3 0.37 -0.01 0.05 0.04 95% 95% 0.3 0.27 -0.00 0.05 0.04 93% 93%
0.4 0.37 -0.00 0.04 0.04 93% 94% 0.4 0.27 0.00 0.03 0.03 94% 94%
0.5 0.36 0.00 0.04 0.03 93% 93% 0.5 0.26 0.00 0.03 0.03 94% 94%
0.6 0.36 0.00 0.04 0.03 94% 94% 0.6 0.26 0.00 0.02 0.02 94% 94%
0.7 0.35 0.00 0.04 0.04 94% 94% 0.7 0.26 0.00 0.02 0.02 94% 94%
0.8 0.35 0.00 0.05 0.05 93% 93% 0.8 0.25 -0.00 0.03 0.03 94% 94%
0.9 0.34 -0.00 0.08 0.07 94% 94% 0.9 0.25 -0.00 0.03 0.03 93% 93%
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Appendix Table 4
Simulation results for m = 300 and ni = 10 for all i, where: α denotes the allocation
probabilities; µa denotes denotes the value of the target parameters µ(100, a, α) for a = 0, 1; Bias
is the average of µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error;
ASE is the average of the sandwich variance based standard error estimates; EC denotes the
empirical coverage of the 95% Wald confidence intervals based on the Normal distribution; and
ECt denotes empirical coverage of t distribution-based Wald CIs.
α µ0 Bias ESE ASE EC ECt α µ1 Bias ESE ASE EC ECt
0.1 0.39 -0.02 0.10 0.09 90% 90% 0.1 0.28 -0.01 0.10 0.09 88% 88%
0.2 0.38 -0.01 0.05 0.05 94% 94% 0.2 0.27 -0.00 0.06 0.05 93% 93%
0.3 0.37 -0.01 0.04 0.04 95% 96% 0.3 0.27 0.00 0.04 0.04 94% 94%
0.4 0.37 -0.00 0.03 0.03 94% 94% 0.4 0.27 0.00 0.03 0.03 93% 93%
0.5 0.36 0.00 0.03 0.03 94% 94% 0.5 0.26 0.00 0.02 0.02 93% 93%
0.6 0.36 0.00 0.03 0.03 93% 93% 0.6 0.26 0.00 0.02 0.02 94% 94%
0.7 0.35 0.00 0.03 0.03 92% 92% 0.7 0.26 0.00 0.02 0.02 93% 93%
0.8 0.35 0.00 0.04 0.04 93% 93% 0.8 0.25 -0.00 0.02 0.02 94% 94%
0.9 0.34 -0.01 0.06 0.06 94% 94% 0.9 0.25 -0.00 0.03 0.03 93% 93%
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Appendix Table 5
Simulation results for m = 400 and ni = 10 for all i, where: α denotes the allocation
probabilities; µa denotes denotes the value of the target parameters µ(100, a, α) for a = 0, 1; Bias
is the average of µ(100, a, α)− µˆ(100, a, α) for a = 0, 1; ESE is the empirical standard error;
ASE is the average of the sandwich variance based standard error estimates; EC denotes the
empirical coverage of the 95% Wald confidence intervals based on the Normal distribution; and
ECt denotes empirical coverage of t distribution-based Wald CIs.
α µ0 Bias ESE ASE EC ECt α µ1 Bias ASE ASE EC ECt
0.1 0.39 -0.02 0.09 0.08 92% 92% 0.1 0.28 -0.01 0.09 0.08 88% 88%
0.2 0.38 -0.01 0.05 0.04 94% 94% 0.2 0.27 -0.00 0.05 0.05 93% 93%
0.3 0.37 -0.00 0.03 0.03 94% 95% 0.3 0.27 -0.00 0.03 0.03 94% 94%
0.4 0.37 0.00 0.03 0.03 95% 95% 0.4 0.27 0.00 0.02 0.02 94% 94%
0.5 0.36 0.00 0.03 0.02 94% 94% 0.5 0.26 0.00 0.02 0.02 93% 93%
0.6 0.36 0.00 0.03 0.02 94% 94% 0.6 0.26 0.00 0.02 0.02 92% 92%
0.7 0.35 0.00 0.03 0.03 94% 94% 0.7 0.26 0.00 0.02 0.02 93% 94%
0.8 0.35 0.00 0.03 0.03 95% 95% 0.8 0.25 -0.00 0.02 0.02 93% 94%
0.9 0.34 -0.00 0.05 0.05 94% 95% 0.9 0.25 -0.00 0.02 0.02 95% 96%
24
